Targeted genetic manipulation using homologous recombination is the method of choice for functional genomic analysis to obtain a detailed view of gene function and phenotype(s). The development of mutant strains with targeted gene deletions, targeted mutations, complemented gene function, and/or tagged genes provides powerful strategies to address gene function, particularly if these genetic manipulations can be efficiently targeted to the gene locus of interest using integration mediated by double cross over homologous recombination.
Introduction
Toxoplasma gondii is a common obligate intracellular protozoan parasite that frequently and chronically infects a wide range of animals and humans 5 . It is estimated that more than 1 billion humans are currently and chronically infected by this pathogen. In addition to the importance of disease caused by T. gondii infection, the increasing availability of experimental tools, powerful genomics resources 6 , ease of in vitro growth and excellent mouse models have made T. gondii a leading model system for the broader study of intracellular eukaryotic pathogens and other significant apicomplexan parasites that cause devastating diseases such as malaria (Plasmodium sp.) and Cryptosporidiosis (Cryptosporidium) 5, 7 . A significant limitation of Toxoplasma gondii as a model organism has been the inefficient recovery of progeny that carry targeted genetic manipulations. This problem in gene targeting is due to a low frequency of homologous recombination relative to the very high frequency of nonhomologous recombination in wild-type strains of T. gondii even when extensive DNA homology is provided in DNA target molecules used in genetic studies 2 .
We recently genetically blocked the major pathway of nonhomologous recombination in type I and type II strains of Toxoplasma gondii by deleting the gene encoding the KU80 protein 1, 2 . The resulting type I and type II Δku80 strains exhibit normal growth rates, size and behavior both in vitro and in vivo during tachyzoite and bradyzoite stages in vitro and in vivo, however, these strains exhibit essentially a 100% frequency of homologous recombination and this phenotype increases the likelihood of rapidly isolating desired progeny of targeted genetic manipulations by several hundred to several thousand-fold Note: The genome sequence of the type II Δku80 strain based on the Pru parental strain is not available at this time. This work uses the type II ME49 genome sequence as the surrogate genome for the type II Δku80 strain. Based on sequence data at a number of genetic loci, it is estimated that the ME49 genome and the Pru genome exhibit single nucleotide polymorphisms at a frequency of ~1 per 10,000 nucleotides, or less.
20. Generate >200 μg of pΔGOI stock by inoculating a ~250 ml 2XYT + AMP overnight culture with glycerol stocks from a validated E. coli miniprep clone. 21. Isolate pΔGOI plasmid DNA from the large culture using a maxiprep DNA isolation kit, resuspending in a final volume of ~1,000 μl. 22. Repeat restriction enzyme digests, or DNA sequencing of the pΔGOI maxiprep DNA to verify the correct targeting DNA molecule prior to transfection. 23. Linearize ~15 μg pΔGOI at the 5' end using the unique restriction enzyme X (RE.X) digest site built into the 5' target flank (Figures 1B).
Note: Gene targeting in T. gondii requires a minimum of ~10 μg of targeting DNA to obtain an efficient frequency of targeting events at the gene locus of interest 
Preparation of T. gondii parasites, transfection, selection, subcloning, validation, archival and maintenance of genetically manipulated strains
General methods for the culture and manipulation of T. gondii in human foreskin fibroblast (HFF) cells are described [19] [20] [21] . The Δku80Δhxgprt strains replicate normally in parasite infection medium (Eagles Minimal Essential Medium (EMEM) growth medium supplemented with 1% fetal bovine serum (FBS) and 1% Antimycotic-Antibiotic diluted from a 100x stock) 1, 2 . All work with Toxoplasma gondii must be performed using biosafety level 2 procedures. The T. gondii RHΔku80 2 parental strain was generated from the RHΔhxgprt strain from the Roos Lab
14
. The PruΔku80 1 parental strain was generated from PruΔhxgprt (Prugniaud strain BSG- 4 22 ) that contains a stably integrated CAT selectable marker and a green fluorescent protein (GFP) reporter under the control of the bradyzoite stage specific promoter LDH2. 
Note:
The isolation of freshly egressed parasites is essential for the success of this protocol because low parasite viability will abolish genetargeting efficiency. Note: Filtering the parasites through the membrane removes infected cells and cellular debris.
5. Determine the parasite concentration (tachyzoite forms per ml) using a hemocytometer.
Optional: Using the parasite solution, set up a plaque forming unit (PFU) assay 21 that will be read 7 -8 days later to determine adequate viability of the transfected parasites (PFU to tachyzoite ratio of ≥0.2).
6. Pellet parasites for 7 min at 1400 x g and aspirate supernatant to ~0.4 ml without disturbing the parasite pellet. Spin for 2 min at 1,400 x g and aspirate remaining supernatant to ~0.01 ml without disturbing the parasite pellet. 7. Resuspend the parasite pellet by flicking the bottom of the tube and immediately add cytomix 23 buffer (1.33x concentration) to the parasite pellet to obtain a parasite concentration of 4 -5 x 10 7 parasites/ml cytomix.
immediately transfer the entire 0.4 ml parasite + pΔGOI mix to a chilled 2 mm gap electroporation cuvette. 10. Electroporate the parasites at 1.4 kV and 24 Ω. 11. Rest the transfection cuvette at room temperature for ~5 min then transfer the entire contents of the transfection cuvette into a 150 cm 2 flask containing confluent HFF cells with 30 ml infection medium and incubate the infected culture overnight. 12. Begin selection in mycophenolic acid + xanthine (MPA + X) ~20 hr post-transfection (Figure 2A ) by replacing the infection medium with MPA + X selection medium (MPA (25 μg/ml) and xanthine (50 μg/ml) in infection medium).
Note: Do not disturb the incubating MPA + X selection flask.
13. Estimate the total number of PFUs in the MPA + X selection flask ~8 days post-transfection by visually inspecting the monolayer. Verify the presence of developing PFUs and healthy zones of infection by light microscopy.
Note: If plaques are not visible by day 8, maintain the selection and monitor for signs of infection since mutant strains may have a reduced replication rate.
Note: The Δku80Δhxgprt parasite strains have an extremely low background of undesired nontargeted events, which allows for the successful isolation of mutant strains with quite severe, but not lethal growth defects. If a gene is essential and it cannot be deleted, the primary transfection, or subsequently passed parasite population, may reveal a phenotype where the parasites cease to replicate during the selection as the population resolves to targeted knockouts. 
The optimal time frame post-transfection for subcloning was established by measuring how rapidly successfully targeted parasites arise at a high frequency in the selected population 19. Continue to passage the primary population of transfected parasites in MPA + X selection medium using a weekly passage schedule of infecting a 25 cm 2 HFF flask with 10 μl of the parasite solution.
Note: If clones carrying the targeted gene deletion (knockouts) are not obtained from the first subcloning in step 18, resubclone the parasites from the continuously maintained population ~10 -12 weeks post-transfection.
One of the reasons a gene deletion is not obtained arises from the episomal persistence of some pΔGOI plasmids. Episomal persistence is determined by the sequences contained in the 5' and the 3' genomic targeting flanks and does not appear to arise from the HXGPRT genetic element. Approximately 5 -10% of targeting plasmids exhibit significant episomal persistence that necessitates a later time of subcloning to allow the parasite population a sufficient number of generation times to dilute the persisting episomes and resolve the population to primarily stable integrants.
20. Score the 96-well tray 6 -7 days post-subcloning (type I parasites) or 7 -8 days post-subcloning (type II parasites) for wells that contain a single PFU, identified as a single zone of infection in light microscopy at either 40X or 60X power. Mark a small dot on the 96-well tray lid to designate the location of the PFU in the well. 21. Mix the contents of each well containing a single PFU using a pipette set at 50 μl (200 μl tip) by directing fluid flow over the PFU to disperse parasites in the well.
Note: Mixing the well accelerates parasite lysis of the HFF monolayer. Type I RH strains will lyse the well ~4 days after mixing, type II Pru parasites will lyse the well ~5 days after mixing.
22. Select a dozen lysed wells (clones) and scratch across the bottom of each of these lysed wells using a 0.5 -10 μl pipette tip while simultaneously drawing-up 6 μl of parasite solution. Transfer the 6 μl of parasite solution to a well in a 24-well tray containing confluent HFF cells in 1 ml MPA + X selection medium.
25. Verify that parasites were successfully transferred to a new 24-well tray by visually inspecting with light microscopy ~18 hr post-passage. 26. Harvest parasites from the lysed wells of the 24-well tray from step 23 -24 using either a 1 ml or 10 ml pipette and transfer the parasite solution to an Eppendorf tube. 27. Pellet the parasites at 1,400 x g for 7 min, rinse once in 1 ml phosphate buffered saline (PBS), and pellet again at 1,400 x g for 3 min. 28. Aspirate PBS from the pellet, then add 200 μl of PBS to the pellet to resuspend the parasites. Freeze the parasite solution at -80 °C until DNA isolation. 29. Isolate parasite DNA from each clone using a tissue DNA isolation minikit. 30. Validate the targeted gene deletion (knockout) by PCR using validation primers (Figures 2A-C) . Test for the absence of the functional coding region of the gene of interest and using the upstream CxF and downstream CxR genomic DNA primers (Figures 2A-B 
Deletion of HXGPRT
This protocol is designed for removing the HXGPRT marker from its integration site in the genome of a genetically manipulated Δku80 strain. Removal of HXGPRT allows for marker recovery and the generation of strains with multiple genetic manipulations using only selections based on HXGPRT [1] [2] [3] . While the protocol detailed below describes the method to re-target a locus to delete HXGPRT, it should be noted that removal of HXGPRT at the gene locus of interest also permits simultaneous re-integration of the wild-type gene (complementation), re-integration of a mutant gene, as well as re-integration of a tagged gene (N-or C-terminal GFP, HA tag, etc,), allowing for a variety of genetic manipulations. The mechanisms of action 24 and targeting protocols using 6-thioxanthine selections have been previously described [1] [2] [3] 15 .
Delete HXGPRT
1. Excise the HXGPRT selectable marker from pΔGOI by digesting with RE.Z to cut at the unique restriction enzyme sites flanking the HXGPRT ( Figure 1B ). 2. Verify complete digestion of DNA by agarose gel electrophoresis. Isolate the larger of the two bands from the agarose gel.
Note:
The larger of the two bands contains the plasmid along with the 5' and 3' DNA target flanks, but not the HXGPRT gene.
3. Place the agarose section containing the larger DNA band in a spin column laying the gel flat on the membrane. Spin the column at 13,000 x g for 4 min at RT. Add sterile H 2 O to the flow-through to bring the volume to 100 μl.
Other commercial methods are available to isolate DNA from agarose. Note: Parasites deleted of the HXGPRT gene replicate at a normal growth rate in 6TX selection.
13. Continue to passage the parasites in 6TX selection medium. 14. Subclone the parasite population after 25 -30 days of selection. Set up one 96-well tray with ~ 1 parasite/well and another with ~ 2 parasites/ well. 15. Prepare parasite DNA from isolated clones and maintain clones in a 24-well format culture according to protocol 1.2 (steps 19 to 29). 16 . Validate deletion of HXGPRT by PCR using the strategy outlined in Figures 3A-B. 
C-terminal Tagging of Proteins
This protocol is designed for C-terminal tagging of proteins by targeting the tag for integration via double cross over homologous recombination at the genomic locus of the gene using MPA + X selection 2, 4 . This protocol works efficiently because the 5' dhfr sequence of the HXGPRT marker is a fully validated functional 3' untranslated region for other genes 2, 4 .
Direct C-terminal tagging of proteins at endogenous genetic loci
1. Create targeting pΔGOItag plasmid construct using yeast recombinational cloning (Figure 4) and methods described in protocol 1.1. The 5' genomic targeting flank contains the last 800 to 1,200 bp of coding region (or genomic DNA) of the GOI, except the termination codon is moved to a position 3' to the tag of choice (HA tag, Myc tag, His tag, etc.) 2. Create the targeted insertion of the C-terminal tag at the endogenous locus of the protein-coding gene by following the steps in protocol 1.1 and 1.2 using the strategy outlined (Figure 4 ). 3. Verify the insertion of the C-terminal tag at the endogenous gene locus using a PCR strategy. 4. Retarget the gene locus using methods described in protocol 1 and protocol 2 to delete the HXGPRT selectable marker to create a precisely regulated endogenous gene locus that expresses a tagged protein. This protocol also recovers the HXGPRT selectable marker that can be used again to target another locus in the tagged strain (see protocol 1).
Representative Results
A detailed template is provided for constructing a targeting plasmid to delete a gene, including the placement of restriction enzyme sites and generation of the primers that facilitate genetic targeting and validation of gene targeting, as well as plasmid construction for the subsequent deletion of HXGPRT in a single-step process (Figures 1A-C, Figure 2A, Figure 3A) . A general schematic is presented for making a targeted gene deletion (Figure 2A) , the primer pairs used to validate the deletion of a knockout, for example, type I rop18 (Figure 2B) , and representative results of the PCR validation are shown ( Figure 2C ). This representative result is shown to illustrate the range of results that can be obtained at genetic loci that are relatively difficult to target. A successfully targeted gene deletion will result in the absence of the gene of interest PCR product (PCR 1), the presence of the 3' genomic targeting flank (PCR2), and the presence of the HXGPRT selectable marker properly integrated between the 5' and 3' genomic targeting flanks that define the deletion (PCR3 and PCR4). Clones 3, 4, 5, 6, 8, 9 , and 11 are validated targeted gene deletions (knockouts) where HXGPRT has replaced the GOI ( Figure 2C) .
A clone that does not contain a gene deletion can be represented by a variety of banding patterns. Typically, a clone without a gene deletion will mirror the parental strain (parental pattern) with bands observed for PCR1 and PCR2, but not for PCR3 or PCR4 as seen for clones 1 and 2 ( Figure 2C ). This "parental pattern" arises from a few potential mechanisms. Occasionally, MPA resistant selected parasites carry nonintegrated persisting episomes of the pΔGOI targeting plasmid, and we note that continued selection often forces these episomes to integrate. We also observe some rare background in the type I Δku80 strain due to unintended integration of the pΔGOI targeting plasmid, which contains a HXGPRT cDNA expressed via DHFR 5' and 3' promoter elements, into either the DHFR locus or into the partially deleted HXGPRT locus 14 . While this rare event is a targeted integration, it was not the intended integration and serves as a key point to remember in designing any gene replacement strategy. DNA homology greater than 120 bp carried on your pΔGOI targeting plasmid may provide an alternative site for recombination in Δku80 strains 2 that could give back an undesired background. In the type II Pru Δku80 strain this background is reduced or nonexistent compared to type I because the HXGPRT selectable marker is based on type I sequences that have nucleotide polymorphisms when compared with type II DNA which greatly reduces this rare background in experiments using the type II Pru Δku80 strain is essential (cannot be deleted), or has an extremely low gene targeting frequency at the locus, or if persisting [nonintegrated] episomes are not easily eliminated via growth and selection, this parental pattern will dominate the pattern observed in MPA resistant clones. Alternatively, the targeting DNA molecule is sometimes observed to integrate at only the 5' or the 3' genomic targeting flank and a band is observed for either PCR3 or PCR4 (but not both) along with PCR1 and PCR2 as seen for clone 10 (5' integration) and clone 7 (3' integration) ( Figure 2C ). These patterns suggest the infrequent occurrence of a single cross over integration of the targeting plasmid at the locus that integrates HXGPRT but this targeted integration does not delete the gene of interest. This pattern (lanes 7 & 10 in Figure 2C ) emphasizes the need to report PCR data to verify that targeted integration occurred instead of a single homologous cross over and a second nonhomologous integration of the targeting molecule. Rarely, we observe a genetic mixture represented by clone 12 ( Figure 2C ) that represents both a parental pattern and a targeted deletion pattern. This pattern most likely arises on occasion from two parasite genotypes that are present at the same location in a cloning well.
A general schematic for the removal of HXGPRT from Δku80Δgoi::HXGPRT to delete HXGPRT from the strain is shown (Figure 3A) . The primer pair used to validate the removal of HXGPRT from Δku80Δgra2::HXGPRT ( Figure 3B ) amplifies a unique ~1.2 Kbp band in PCR5 as seen in clones 4, 7, 9, 11 and 12 ( Figure 3C ). If HXGPRT is not removed from the locus, a ~3.4 Kbp band is observed (clones 1, 2, 3, 6, 8, 10 , and the parental control). Several mechanisms act to make the removal of HXGPRT (6TX selection) more challenging and less efficient than the integration of HXGPRT (MPA + X selection). MPA selection is simply more efficient than 6TX selection 14, 16 . In addition, higher levels of HXGPRT expression are needed for 6TX selection than for MPA selections 16, 24 . Consequently, mutations that may reduce HXGPRT enzyme activity or mutations or epigenetic changes that reduce the expression level of HXGPRT at a gene's locus can potentially abolish the effectiveness of 6TX selection. Even with these challenges of 6TX selection, the success rate of 6TX selection in Δku80 strains is greater than 90% on the first attempt [1] [2] [3] .
A general scheme for direct C-terminal tagging of protein-coding genes is shown (Figure 4) . This scheme uses direct integration via double cross over homologous recombination of HXGPRT 3' of the tagged gene and also employs validation strategies similar to those described above. When a gene is suspected to be an essential gene this can be verified using a second transfection with an independently isolated targeting DNA plasmid. Alternative methods, such as schemes for regulated gene expression, are available for further verifying if a gene is essential 25 . Figure 1 . Overview of the design of a targeting DNA plasmid. A. Schematic for designing overlap primers used to PCR amplify the 5' and 3' target flanks with 33 bp overlaps for the pRS416 shuttle vector and HXGPRT minigene cassette. Primers depicted in the schematic were used to generate the 5' and 3' target flanks of pΔROP18 10 . B. Overall strategy for designing a targeting DNA molecule. The backbone of pΔGOI is the pRS416 shuttle vector containing uracil (URA) and ampicillin (AMP) selectable markers. Inserted into pRS416 is a ~1 Kbp 5' DNA target flank amplified from genomic DNA with overlaps for the HXGPRT minigene cassette and pRS416 using the F1 and R1 primers, a ~1 Kbp 3' DNA target flank is amplified from genomic DNA with overlaps for the HXGPRT minigene cassette and pRS416 using the F2 and R2 primers and the HXGPRT minigene cassette. The following unique restriction enzyme digest sites are added to the primers: RE.X (restriction enzyme X cut site) in the F1 primer to cut the plasmid at the 5' end of the 5' DNA target flank, RE.Y in the R2 primer to cut the plasmid at the 3' end of the 3' DNA target flank and RE.Z in the R1 and F2 primers to excise the HXGPRT minigene cassette. C. Primer sequences used to generate the targeting construct for the deletion of rop18. The bold regions correspond to T. gondii genomic sequence, and the nonbold regions correspond to the restriction enzyme sites and sequences that overlap with pRS416 and the HXGPRT minigene cassette. The HX_F and HX_R primer pair amplifies the HXGPRT minigene cassette 14 . Primers read from 5' to 3'. Table adapted from Fentress et al 
